Mechanistically, CD36 is selectively upregulated in intratumoral Treg cells and enhances mitochondrial fitness via peroxisome proliferator-activated receptor-β (PPARβ) signaling, rewiring Tregs to adapt to a lactate-enriched tumor microenvironment (Wang et al, 2020). The gene discussed is CD36; the disease is neoplasm.